Actively Recruiting
Long-term Safety and Efficacy of GBG Study Participants
Led by GBG Forschungs GmbH · Updated on 2024-10-02
400
Participants Needed
3
Research Sites
396 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The ETERNITY study is an international, multicenter, observational study that aims to follow up patients who have participated in a GBG trial for early breast cancer, even after the study has officially ended, in order to collect long-term data on survival, late or delayed adverse events, in addition to information related to pregnancy, fertility and other parameters impacting quality of life.
CONDITIONS
Official Title
Long-term Safety and Efficacy of GBG Study Participants
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participation and treatment in a GBG clinical trial for early breast cancer.
- Written informed consent given according to local regulatory requirements before data and biomaterial collection.
You will not qualify if you...
- Participation and treatment in a non-GBG clinical trial for early breast cancer.
- Patients with advanced or metastatic breast cancer who have participated and received treatment in a GBG clinical trial.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
MUI - Univ. Klinik f. Frauenheilkunde Innsbruck
Innsbruck, Austria, 6020
Actively Recruiting
2
Ordensklinikum Linz GmbH - BHS
Linz, Austria, 4020
Actively Recruiting
3
LKH Salzburg - PMU
Salzburg, Austria, 5020
Actively Recruiting
Research Team
T
Thomas Ballhausen, Dr.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here